CDC adds new diagnostic codes to document detransitioning and related care
The CDC will introduce specific diagnosis codes in October to record detransitioning for insurance billing and data tracking.
In October, the Centers for Disease Control and Prevention will add a set of diagnosis codes that recognize detransitioning, allowing clinicians to bill insurers and collect data on patients who discontinue gender-transition care. The initiative was shaped with input from the medical watchdog Do No Harm, whose chief medical officer Kurt Miceli described the codes as a way to make detransitioners visible within the health system.
Among the new entries is "Gender Identity Disorder, in remission" and three additional codes covering personal histories of social, medical, and surgical gender transition. Advocates argue the classifications will help document the harms of irreversible procedures and support research into reversal outcomes. Vice President J.D.
Vance recently urged criminal prosecution of providers he says fraudulently use billing codes to cover what he calls "castration and genital mutilation" of minors. The CDC’s action is intended to give detransitioners better access to care and to generate statistics on regret rates that have long been hidden.
Why it matters
The new codes could affect insurance coverage and data on the outcomes of gender-transition treatments.
In this story
